Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

899 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vasculitis associated with VEXAS syndrome.
Sullivan M, Mead-Harvey C, Sartori-Valinotti JC, Kalantari K, Kusne YN, Patnaik M, Mangaonkar AA, Go R, Montes D, Reichard K, Olteanu H, Bois M, Hines A, Warrington K, Koster MJ. Sullivan M, et al. Among authors: go r. Rheumatology (Oxford). 2024 Oct 11:keae550. doi: 10.1093/rheumatology/keae550. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39392442
Acute kidney injury, an underrecognized feature of VEXAS syndrome.
Kalantari K, Sullivan MM, Hernandez LPH, Bu L, Cornell LD, Nasr SH, Fervenza FC, Montes D, Mangaonkar AA, Go RS, Kusne YN, Patnaik MM, Lasho TL, Olteanu H, Reichard KK, Warrington KJ, Koster MJ. Kalantari K, et al. Rheumatology (Oxford). 2024 Aug 26:keae465. doi: 10.1093/rheumatology/keae465. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39186250
BCR-ABL testing in the evaluation of neutrophilia.
Smith CJ, Ruan GJ, Kluck LA, Maberry M, Go RS. Smith CJ, et al. Am J Hematol. 2024 Aug;99(8):1651-1654. doi: 10.1002/ajh.27373. Epub 2024 May 17. Am J Hematol. 2024. PMID: 38760992 No abstract available.
Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience.
Lazaridis KN, Schahl KA, Cousin MA, Babovic-Vuksanovic D, Riegert-Johnson DL, Gavrilova RH, McAllister TM, Lindor NM, Abraham RS, Ackerman MJ, Pichurin PN, Deyle DR, Gavrilov DK, Hand JL, Klee EW, Stephens MC, Wick MJ, Atkinson EJ, Linden DR, Ferber MJ, Wieben ED, Farrugia G; Individualized Medicine Clinic Members. Lazaridis KN, et al. Mayo Clin Proc. 2016 Mar;91(3):297-307. doi: 10.1016/j.mayocp.2015.12.018. Mayo Clin Proc. 2016. PMID: 26944241
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group.
Go RS, Winters JL, Leung N, Murray DL, Willrich MA, Abraham RS, Amer H, Hogan WJ, Marshall AL, Sethi S, Tran CL, Chen D, Pruthi RK, Ashrani AA, Fervenza FC, Cramer CH 2nd, Rodriguez V, Wolanskyj AP, Thomé SD, Hook CC; Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy Disease-Oriented Group. Go RS, et al. Mayo Clin Proc. 2016 Sep;91(9):1189-211. doi: 10.1016/j.mayocp.2016.05.015. Epub 2016 Aug 3. Mayo Clin Proc. 2016. PMID: 27497856
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations.
Smith KER, Acosta-Medina AA, Dasari S, Ranatunga W, Rech KL, Ravindran A, Young JR, McGarrah PW, Ruan GJ, Zanwar SS, Li JJ, Sartori-Valinotti JC, Snider JN, Witzig TE, Goyal G, Go RS, Abeykoon JP. Smith KER, et al. Among authors: go rs. JCO Precis Oncol. 2024 Nov;8:e2400471. doi: 10.1200/PO-24-00471. Epub 2024 Nov 22. JCO Precis Oncol. 2024. PMID: 39576953
899 results